top of page
NEXGEN-PD_Logo_RGB.jpg

Next Generation Vaccine Platform

Leveraging Skin Immunity

to Provide Disease-Modifying Treatment

of Parkinson’s Disease

NEXGEN is a Horizon Europe Research and Innovation Project aiming to revolutionise the treatment and diagnosis of Parkinson's. NEXGEN pioneers a new vaccine platform which produces substantially stronger immune responses than any existing vaccines, and develops a new diagnostic assay to detect biomarkers of Parkinson's in blood and urine for earlier detection. Combined together, NEXGEN marks the beginning of a new generation of solutions for Parkinson's and other non communicable diseases, substantially improving the lives of millions.

 

See our About page for more details about what is so special about the vaccines and diagnostic assays developed in NEXGEN and what activities are taking place during the project. 

Contact
Info

  • LinkedIn

Join our mailing list to receive regular updates on NEXGEN's progress

Thanks for submitting!

This project has received funding from the EU Horizon Europe Research and Innovation programme under grant agreement no 101080267.  

UK participants in this project is supported by UKRI grant number 10064393. 

©2023 by Modus Research and Innovation

bottom of page